Companies / Generation Bio Co.

Generation Bio Co.

GBIOCIK 1733294CAMBRIDGE, MA

Financials ยท FY2024

Revenue$19.89M
Net income$-131.67M
Total debtโ€”
Cash$21.94M
Diluted EPS$-1.98
Shares outstanding6.7M

Ownership

6.7M shares outstanding ยท as of Oct 31, 2025
7.4%10%+ / strategic
Ownership
10%+ / strategic7.38%497,255
Public float92.62%6,240,644

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all โ†’
Insider% of sharesShares
0.00%0
0.00%0
0.00%0
Conway Kevin JohnFormerCHIEF FINANCIAL OFFICER
0.00%0
0.00%0
Howze YalondaCEOFormerINTERIM CEO AND PRESIDENT
0.00%0
0.00%0
0.00%0
0.00%0
0.00%0

Institutional holders 0

HolderValue% of shares
No institutional holders on file.
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ฮ”Position afterImpact
Feb 2, 2026McDonough Geoff
Director
OtherCommon Stock$3.1K-550
-0.40%
138,492
2.06% of shares
low
Feb 2, 2026Howze Yalonda
CEO
OtherCommon Stock$2.8K-495
-11.64%
3,759
0.06% of shares
low
Jan 15, 2026McDonough Geoff
Director
OtherCommon Stock$773-137
-0.10%
137,460
2.04% of shares
low
Jan 15, 2026Howze Yalonda
CEO
OtherCommon Stock$558-99
-3.69%
2,581
0.04% of shares
low
Feb 2, 2026Conway Kevin John
Executive
OtherCommon Stock$406-72
-3.36%
2,072
0.03% of shares
low
Jan 15, 2026Conway Kevin John
Executive
OtherCommon Stock$96-17
-0.88%
1,909
0.03% of shares
low
Feb 9, 2026Howze Yalonda
CEO
OtherStock Option (right to buy)โ€”-8K
-100.00%
0
0.00% of shares
low
Feb 9, 2026Howze Yalonda
CEO
OtherStock Option (right to buy)โ€”-25K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Renaissance Technologies LLCPassive13G/Aโ€”287,614โ€”
Baselake Partners, LPPassive13G/Aโ€”โ€”โ€”
T. Rowe Price Associates, Inc.Passive13G/Aโ€”209,641โ€”
Baselake Partners, LPPassive13Gโ€”โ€”โ€”